MiR-335 binds to 3′-UTR of SIAH2 and decreases expression of SIAH2, which in turn increases the expression of HDAC3 to confer anti-cancer drug sensitivity in anti-cancer drug-sensitive melanoma cells, such as Malme3M cells [64] (Figure 2A). Here, HDAC3 is linked to melanoma.